Marketing-authorisation holder
Forest Labs
19 medicines in 2 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
19 medicines in 2 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
19 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMBENYL12.5mg/5ml; 10mg/5ml · Syrup | Bromodiphenhydramine, Codeine | United States | Not marketed | 1954 |
| BETAPRONESolution | Propiolactone n/a | United States | Not marketed | 1959 |
| CAMPRAL333MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed release | Acamprosate | United States | Not marketed | 2004 |
| CELEXA10MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Citalopram | United States | Not marketed | 1999 |
| COMBUNOX400MG; 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ibuprofen, Oxycodone | United States | Not marketed | 2004 |
| DURAPHYL100mg | 200mg | 300mg · Tablet, extended release | Theophylline | United States | Not marketed | 1985 |
| ELIXICON100mg/5ml · Suspension | Theophylline | United States | Not marketed | |
| ELIXOPHYLLIN100mg | 200mg · Capsule | Theophylline | United States | Not marketed | 1984 |
| ELIXOPHYLLIN SR125mg | 250mg · Capsule, extended release | Theophylline | United States | Not marketed | 1998 |
| FLUMADINE50mg/5ml · Syrup | Rimantadine | United States | Not marketed | 1993 |
| FORBAXIN750mg · Tablet | Methocarbamol | United States | Not marketed | |
| PYOCIDIN5mg/ml; 10,000 units base/ml · Solution/drops | Hydrocortisone, Polymyxin b | United States | Not marketed | 1972 |
| SUS-PHRINE SULFITE FREE1.5mg/amp | 5mg/ml · Injectable | Epinephrine | United States | Not marketed | 1951 |
| THEOCHRON SRT 100MG100 mg / tab · Tablet (Extended-Release) | Theophylline | Canada | Cancelled | 1985 |
| THEOCHRON SRT 200MG200 mg / tab · Tablet (Extended-Release) | Theophylline | Canada | Cancelled | 1985 |
| THEOCHRON SRT 300MG300 mg / tab · Tablet (Extended-Release) | Theophylline | Canada | Cancelled | 1985 |
| THEOPHYLLINE SRT 300MG300 mg / tab · Tablet (Extended-Release) | Theophylline | Canada | Cancelled | 1985 |
| THEOPHYLLINE SUSTAINED RELEASE TAB 100MG100 mg / tab · Tablet (Extended-Release) | Theophylline | Canada | Cancelled | 1985 |
| THEOPHYLLINE SUSTAINED RELEASE TAB 200MG200 mg / tab · Tablet (Extended-Release) | Theophylline | Canada | Cancelled | 1985 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 13 | 13 | 0 | CompaniesAll medicines |
| Canada | 6 | 0 | 6 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.